Located just outside WASHINGTON DC
, The Degge Group
provides consulting services to the biopharmaceutical and medical
products sector specializing in clinical drug safety,
pharmacovigilance, medical product epidemiology, and risk management.
Degge's staff has contributed to the burgeoning fields of
pharmacoepidemiology and pharmacovigilance for over two decades and
has worked to enhance the understanding of drug safety, drug use,
natural history of disease studies, risk evaluation and mitigation
strategies (REMS), benefit-risk assessments, and pharmacoeconomic and
Degge will help you identify and analyze key data to meet your needs.
- Our latest publication: Intranasal Fluticasone Propionate Observational Cohort Safety Studies: Reviewing Evidence from Databases on Two Continents” was recently published with open access in Drugs – Real World Outcomes. Coauthors included Earl Goehring Jr, and Judith K Jones, MD, PhD, FISPE.